Magnetic-particle chemiluminescence kit used for detecting monensin and applications of the kit
A chemiluminescence reagent, the technology of monensin, which is applied to a magnetic particle chemiluminescence kit for detecting monensin and its application field, can solve the problem of low false positive rate, influence of reaction time and temperature, poor reagent stability, etc. problem, to achieve the effect of low detection time, fast detection and high sensitivity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Example Embodiment
[0035] Example 1 Preparation of specific components of the kit
[0036] 1) Preparation of monensin artificial antigen
[0037] The immunogen was obtained by coupling monensin with bovine serum albumin (BSA) by activated ester method (NHS-DCC).
[0038] 3) Preparation of monoclonal antibodies
[0039] Animal immunization: Balb / c mice were immunized with immunogen at a dose of 100 μg / mice to produce antiserum.
[0040] Cell fusion and cloning: take the spleen cells of immunized Balb / c mice and fuse with SP2 / 0 myeloma cells in a ratio of 9:1 to obtain a hybridoma cell line of monoclonal antibody.
[0041] Cell cryopreservation and recovery: make 1×10 hybridoma cells with cryopreservation solution 9 cells / ml, and stored in liquid nitrogen for a long time. When resuscitated, take out the cryopreservation tube, immediately put it into a 37°C water bath to thaw quickly, remove the cryopreservation solution by centrifugation, and transfer it to a culture bottle for culture.
[00...
Example Embodiment
[0052] Example 2 Construction of the kit
[0053] A magnetic particle direct competition chemiluminescence detection kit for the detection of monensin was constructed to contain the following components:
[0054] Fluorescent label for FITC-labeled monensin monoclonal antibody
[0055] Luminescent label for ABEI-labeled monensin hapten
[0056] Separation reagent for paramagnetic nanobeads coated with goat anti-FITC monoclonal antibody
[0057] Monensin standard solution (0ng / ml, 0.02ng / ml, 0.06ng / ml, 0.18ng / ml, 0.54ng / ml, 1.6ng / ml), the standard dilution solution is pH7.2, 0.03%NaN 3 , 0.1mol / L PBS buffer. The percentage content is the mass percentage content.
[0058] The concentration of monens quality control solution is 0.05ng / ml, 1.0ng / ml, and the dilution of quality control solution is pH7.2, 0.03%NaN 3 , 0.1mol / L PBS buffer. The percentage content is the mass percentage content.
[0059] The concentrated wash solution is pH7.2, 0.2-0.4% Tween-20, 0.02-0.04% NaN ...
Example Embodiment
[0060] Embodiment 3 Detection of monensin in actual samples
[0061] 1. Sample pretreatment
[0062] (1) Pork / liver pretreatment method
[0063] Homogenize the sample with a homogenizer; weigh 3.0±0.05g of the homogenate into a 50ml polystyrene centrifuge tube, add 5ml methanol, then add 1ml deionized water, shake for 5min, above 3000g, room temperature (20-25℃) Centrifuge for 5min; take 2ml of supernatant into a 50ml plastic centrifuge tube, add 2ml of 1M sodium hydroxide solution and mix, then add 6ml of n-hexane, vortex for 3min, centrifuge at 3000g or more at room temperature (20-25℃) for 5min; take 3ml Transfer the supernatant to a 10ml glass test tube, blow dry under nitrogen flow at 50-60°C, add 1ml of reconstituted working solution and vortex for 2-3min; take 50μl for analysis, sample dilution ratio: 2.
[0064] (2) Pre-treatment method of chicken / liver
[0065] Homogenize the sample with a homogenizer; weigh 3.0±0.05g of the homogenate into a 50ml polystyrene centr...
PUM
Property | Measurement | Unit |
---|---|---|
Sensitivity | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap